Real-time enrollment status for this eosinophilic granulomatosis with polyangiitis (egpa) clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 6:25 AM UTC
| NCT Number | NCT06512883 |
| Recruiting Status | Recruiting |
| Condition | Eosinophilic Granulomatosis With Polyangiitis (EGPA) |
| Phase | PHASE3 |
| Target Enrollment | 14 participants |
| Active Locations | 3 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 30, 2026 (3 weeks ago) |
As of July 21, 2026: Clinical trial NCT06512883 is currently recruiting participants. This phase3 study for eosinophilic granulomatosis with polyangiitis (egpa) is actively seeking new participants at 3 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06512883 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06512883 was last updated 3 weeks ago (June 30, 2026). HelloStudys verifies this status automatically.